Journal article
95O Atezolizumab plus ipatasertib shows promise in extending survival for patients with PI3K/AKT/PTEN-altered advanced solid tumors: An exploratory analysis of the ROME trial
Authors
Botticelli A; Lonardi S; Lombardi G; Curigliano G; Scagnoli S; Pisegna S; Crimini E; Verkhovskaia S; Cremolini C; Capoluongo E
Journal
ESMO Open, Vol. 10, ,
Publisher
Elsevier
Publication Date
March 1, 2025
DOI
10.1016/j.esmoop.2025.104256
ISSN
2059-7029